Rocket Pharmaceuticals, Inc.

9IP1.F·Frankfurt·Healthcare
Compare
1.8550+0.0700 (+3.92%)today
At close: Oct 23, 8:03 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.7850
Open1.8550
Day range—
52-week range1.77004.6720
Off day high0.00%
Off 52-week high−60.30%
Volume1.30K
Avg. volume (3M)20.00
Market cap203.63M
EPS (TTM)-0.1500
Forward P/E-0.72
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.50
Shares outstanding109.77M
Short interest—
Earnings dateNov 5, 2026 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
9IP1.F LXEO SLDB TNYA RNA RGNX
Market cap 203.63M 229.85M 634.77M 87.23M 140.27M 440.97M
P/E (TTM) — — — — — —
Forward P/E -0.7 -2.1 -3.5 -1.0 -1.4 -2.2
Price/book 0.6 0.9 1.7 1.3 0.7 5.0
Dividend yield — — — — — —
1-year change −45.33% −68.69% +10.14% −76.57% −44.68% −44.97%
Today +3.92% −3.11% −4.36% +0.26% +0.49% −6.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 9IP1.F news ›
MarketScreener·

Rocket Pharmaceuticals, Inc. : Insider Transactions

Follow insider transactions on Rocket Pharmaceuticals, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Rocket Pharmaceuticals, Inc. Biotechnology & Medical…

MarketScreener·

Rocket Pharmaceuticals, Inc. Announces Executive Changes

Rocket Pharmaceuticals, Inc. announced that on June 24, 2026, John Militello informed the company of his resignation as Senior Controller, Treasurer and Principal Accounting Officer, effective July 7,... announced that on June 24, 2026,…

MarketScreener·Positive

Transcript : Rocket Pharmaceuticals, Inc. - Special Call

Presentation Operator MessageOperator Good day, and welcome to the Rocket Pharmaceuticals Investor Program Update on Danon disease and the RP-A501 pivotal Phase II trial. As a reminder, today's... Transcript : Rocket Pharmaceuticals, Inc.…

From articles in the 4Search news index.

In the news

30mentions in 30 days
30with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.